Results 101 to 110 of about 6,272,911 (310)
Therapeutic drug monitoring of voriconazole
Invasive fungal diseases are associated with significant morbidity and mortality, especially in immunocompromised patients. Voriconazole is a first-line treatment for invasive aspergillosis, and an effective agent for candidiasis, fusariosis and ...
VIALE, PIERLUIGI, LEWIS, RUSSEL EDWARD
core
Azathioprine and 6-mercaptopurine are often used in the treatment of patients with inflammatory bowel disease (IBD). They are prodrugs and undergo a complex metabolism to active and inactive metabolites.
Peterson, Curt, +3 more
core +1 more source
Therapeutic Drug Monitoring [PDF]
Ramona, Dolscheid-Pommerich +1 more
openaire +2 more sources
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Total plasma concentrations are used for therapeutic drug monitoring of antiretroviral drugs, whereas antiviral activity is expected to depend on unbound concentrations.
Thierry Buclin +21 more
core +1 more source
Mirtazapine pharmacokinctic (PK) data from patients on long-term treatment for major depression have never been investigated. For this reason, in a large naturalistic outpatient study (prospective, multicenter, open-labeled, and noncomparative) conducted
Reis, Margareta, +5 more
core +2 more sources
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq +8 more
wiley +1 more source
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach +9 more
wiley +1 more source
Therapeutic drug monitoring of erlotinib in non-small cell lung carcinoma: A case study
We describe a clinical case of an 84-year-old man diagnosed with non-small cell lung carcinoma (NSCLC) and epidermal growth factor receptor (EGFR) mutation, who was treated with erlotinib, with doses adjusted by therapeutic drug monitoring (TDM).
Sureda, Manuel +3 more
core +1 more source
Objectives: This study aims to examine whether the allograft inflammatory factor-1 (AIF1) gene rs2269475:C>T polymorphism is associated with rheumatoid arthritis (RA) susceptibility, and whether this polymorphism influences disease activity in patients ...
Andrzej PAWLIK +3 more
doaj

